Hepatobiliary Metastasis of Colorectal Cancer in a Frail Patient and the Role of Immunohistochemistry and Endoscopic Retrograde Cholangiopancreatography (ERCP): A Case Report
Open Access
- 9 September 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e28979
Abstract
Primary cholangiocarcinoma (malignancy of the bile ducts) is potentially a treatable malignancy via surgery. It presents with a derangement in the liver function blood test results, which results in raised bilirubin. It may also be accompanied by the complaint of itching of skin, dark urine, and light color stool. Bile duct metastasis from primary colorectal cancer, although a very rare condition presents with similar symptomatology and blood test results. Immunohistochemistry staining of tissue biopsy has significantly improved differentiation, detection, and hence plan management of both malignancies (cholangiocarcinoma and bile duct metastasis from primary colorectal cancer). The role of endoscopic retrograde cholangiopancreatography (ERCP) is important with the insertion of a stent towards symptom relief when palliative management is indicated in patients with an incurable disease.Keywords
This publication has 16 references indexed in Scilit:
- Global patterns and trends in colorectal cancer incidence and mortalityGut, 2016
- Intrapancreatic bile duct metastasis from colon cancer after resection of liver metastasis with intrabiliary growth: a case reportWorld Journal of Surgical Oncology, 2015
- Incidence and patterns of late recurrences in colon cancer patientsInternational Journal of Cancer, 2015
- Metástasis biliares intraductales de carcinoma colorrectal: a propósito de 2 casosRadiologia, 2014
- The molecular genetics of colorectal cancerFrontline Gastroenterology, 2013
- Intraductal papillary growth of liver metastasis originating from colon carcinoma in the bile duct: Report of a caseSurgery Today, 2011
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesLaboratory Investigation, 2000
- Villous adenoma of the common hepatic duct: the role of ultrasound in management.Gut, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988